The Use of High Dose Eltrombopag in the Management of Sepsis-Associated Thrombocytopenia in Critically Ill Patients
Sepsis is a life-threatening condition, and sepsis-associated thrombocytopenia (SAT) is a common consequence of the disease where platelet count falls drastically within a very short time. Multiple key factors may cause platelet over-activation, destruction and reduction in platelet production durin...
Main Authors: | Hasan Md. Jahidul, Rabbani Raihan, Huq Shihan Mahmud Redwanul |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-11-01
|
Series: | The Journal of Critical Care Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/jccm-2019-0019 |
Similar Items
-
Eltrombopag Use for Treatment of Thrombocytopenia in a Patient with Chronic Liver Disease and Portal Vein Thrombosis: Case Report
by: Sabah E. Mohamed, et al.
Published: (2020-07-01) -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
by: Alhossain A. Khalafallah, et al.
Published: (2012-01-01) -
PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA
by: Roberto Stasi, et al.
Published: (2009-11-01) -
Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia
by: Angelica Maria Garzon, et al.
Published: (2015-08-01) -
Use of Eltrombopag in Children With Chronic Immune Thrombocytopenia (ITP): A Real Life Retrospective Multicenter Experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)
by: Paola Giordano, et al.
Published: (2020-02-01)